Active Ingredient(s): Desonide
FDA Approved: * September 19, 2006
Pharm Company: * CONNETICS
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Verdeso Overview

Desonide (INN) is a low-potency topical corticosteroid anti-inflammatory that has been available since the 1970s. It is primarily used to treat atopic dermatitis (eczema), seborrheic dermatitis, contact dermatitis and psoriasis in both adults and children. It has a fairly good safety profile[1] and is available as a cream, ointment, lotion, and as a foam under the tradename Verdeso Foam. Other trade names for creams, lotions, and ointments include Tridesilon, DesOwen, Desonat...

Read more Verdeso Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Verdeso Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Aerosol, Foam: 0.05%
  • Cream: 0.05%
  • Foam: 0.05%
  • Gel: 0.05%
  • Lotion: 0.05%
  • Ointment: 0.05%
  • Solution/drops: 2% + 0.05%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Verdeso: (2 results)

Sorted by National Drug Code
  • 16110-111 Verdeso .5 mg/g Topical Aerosol, Foam by Aqua Pharmaceuticals
  • 63032-111 Verdeso .5 mg/g Topical Aerosol, Foam by Stiefel Laboratories Inc

Other drugs which contain Desonide or a similar ingredient: (15 results)